Vardenafil Dosage

Other > vardenafil tablets


The American Journal of Cardiology, 93(9), 1378-1383. Pharmacology and drug-interaction effects of phosphodiesterase 5 inhibitors.

  • Vardenafil is effective for up to 4-5 hours.
  • Do not use if allergic to vardenafil or similar drugs.
  • Overdose symptoms may include prolonged erections.
  • Medical advice is essential for any severe side effects.

International Journal of Clinical Practice, 59(9), 1165-1170. Ocular side effects of vardenafil: Results of a double-blind study.

Can erectile dysfunction be a sign of another health condition?

The erectile response is a neurovascular event initiated by parasympathetic-mediated nitric oxide (NO) release from cavernous nerve terminals and endothelial cells. NO stimulates guanylate cyclase, increasing intracellular cGMP, which in turn lowers intracellular calcium and relaxes trabecular smooth muscle. PDE5 terminates this signal by hydrolyzing cGMP to its inactive 5′ monophosphate. Vardenafil binds selectively and reversibly to the catalytic site of PDE5, raising cGMP concentrations and amplifying the natural erectile cascade in the presence of sexual arousal. In vitro affinity profiling demonstrates that vardenafil exhibits a 10- to 20-fold greater potency against PDE5 than sildenafil and maintains over 1000-fold selectivity versus other cyclic nucleotide phosphodiesterases, including the cardiac isoenzyme PDE3 and retinal PDE6.

Dosage for people with liver disease

This selectivity profile reduces the likelihood of off-target hemodynamic or visual disturbances, although minor, transient alterations in color discrimination have been documented. These interactions stabilize the inhibitor-enzyme complex, yielding an inhibitory constant (K_i) in the low nanomolar range. Following oral ingestion of a 20 mg tablet, mean vardenafil C_max approximates 20 ng mL⁻¹, with systemic exposure proportional across a 5-20 mg dose span. Metabolic clearance is dominated by oxidative N-dealkylation and ring hydroxylation, producing an active metabolite (M1) that retains ~28 % of parent potency but constitutes less than 7 % of the circulating molar fraction. Because PDE5 predominates in erectile tissue, systemic vasodilatory effects are typically modest at therapeutic doses. The Journal of Sexual Medicine, 17(11), 2057-2065.

Condition Explanation
Use with Nitrates Can cause severe hypotension
Severe Liver Impairment Metabolism may be impaired, risk of accumulation
Retinitis Pigmentosa Potential risk of worsening vision
Hypotension or Uncontrolled Hypertension Risks of blood pressure fluctuations

Cardiac safety in clinical trials of PDE5 inhibitors. Cardiology in Review, 13(4), 213-220.

Product Dosage Quantity + Bonus Price
Kamagra Gold100 mg60 + 4 Pills201.34€ 191.75€
Viagra Generic150mg20 Pills55.02€ 52.40€
Levitra Generic20mg360 + 10 Pills458.44€ 436.61€
Levitra Generic20mg270 + 10 Pills376.33€ 358.41€
Levitra Original20mg64 + 4 Pills298.45€ 284.24€
Cialis Generic60mg30 + 2 Pills85.33€ 81.27€
Viagra Oral Jelly100mg10 Sachets46.36€ 44.15€
Kamagra Polo100mg272 + 12 Pills622.94€ 593.28€
Cialis Original20mg4 Pills41.99€ 39.99€
Viagra Generic50mg30 + 4 Pills54.26€ 51.68€
Cialis Soft Tabs20mg20 + 2 Pills66.98€ 63.79€
Viagra Oral Jelly100mg63 + 7 Sachets190.54€ 181.47€
Kamagra100mg12 Pills55.64€ 52.99€

Simultaneous administration of vardenafil and tamsulosin in benign prostatic hyperplasia.

ICO Registered Website

Visual disturbances, predominantly a blue-green tinge or increased light sensitivity, occurred in ≤ 2% of subjects and resolved within hours of dosing cessation, consistent with transient PDE6 inhibition. Although rare, priapism-painful erections persisting beyond four hours-has been associated with PDE5 inhibitors, including vardenafil. Post-marketing pharmacovigilance identified fewer than 1 case per 50,000 prescriptions, yet the potential for irreversible tissue ischemia necessitates prompt medical intervention for prolonged erections. Counsel patients to seek emergency care if tumescence exceeds four hours. Additional serious but uncommon adverse events comprise sudden sensorineural hearing loss, non-arteritic anterior ischemic optic neuropathy, and myocardial infarction in predisposed individuals; establishing causality is challenging due to confounding vascular risk factors inherent to the target population.

Other Medical Problems

Cardiac electrophysiology investigations have shown man up pills small QTc prolongations that generally lack clinical consequence but underscore the need to avoid concomitant class IA or III anti-arrhythmic agents. Similarly, isolated reports of ventricular arrhythmias are confounded by underlying structural heart disease. Post-authorization safety studies continue to monitor hepatic toxicity, hypersensitivity reactions, and potential drug-drug interactions, reinforcing the importance of ongoing pharmacovigilance in commercial preparations. Vardenafil is not indicated for use in women and carries no established therapeutic role during pregnancy. Animal reproduction studies conducted with doses generating exposures up to 18-fold higher than typical human AUC did not reveal teratogenicity, but delayed ossification and decreased neonatal survival were observed at maternally toxic doses, signifying class-related hemodynamic effects on uteroplacental perfusion. Optimization of factors affecting vardenafil absorption using β-cyclodextrin.

Risks and warnings for Vardenafil

Because mechanistic data suggest theoretical impacts on vascular tone, the risk-benefit ratio for any off-label maternal use (e.g., pulmonary hypertension) remains uncertain. Current FDA guidance on reproduction-development toxicity testing stipulates that embryo-fetal development studies in at least two species (usually rats and rabbits) inform labeling when systemic maternal exposure approximates or exceeds anticipated clinical exposure. Safety extrapolation to humans relies on allometric scaling, placental transfer kinetics, and species-specific pharmacodynamics; therefore, absent positive human data, vardenafil should be avoided throughout pregnancy, and effective contraception is advised for women of reproductive potential participating in investigational protocols. Store vardenafil tablets at controlled room temperature, 20-25 °C (68-77 °F), with permissible excursions between 15 °C and 30 °C. Vardenafil for the treatment of erectile dysfunction: A critical review.

What are the most common side effects of vardenafil?

Phosphodiesterase 5: Structure-function regulation and selectivity. PubChem compound summary for CID 135400189, vardenafil. Risk of death in patients with coronary artery disease taking phosphodiesterase 5 inhibitors. Journal of the American College of Cardiology, 82(12), 1123-1135. Evaluation of vardenafil on cardiac repolarization in healthy men. Pharmaceutical Development and Technology, 24(3), 354-364.

Liver Dose Adjustments

Pharmacokinetic interactions largely stem from vardenafil’s metabolism by CYP3A4. For example, concomitant ketoconazole 400 mg once daily increased vardenafil area under the curve (AUC) nearly ten-fold; under such circumstances, dosing should not exceed 2.5 mg in 24 hours. Combined use with α-adrenergic blockers (e.g., doxazosin, terazosin) may potentiate orthostatic hypotension due to overlapping vasodilatory effects. Titrate the α-blocker to a stable maintenance dose and ensure hemodynamic stability before introducing vardenafil at the lowest feasible dose. Clinical pharmacology trials evaluating co-administration with tamsulosin 0.4 mg daily demonstrated no clinically significant blood-pressure reductions when vardenafil was given two hours after the α-blocker, underscoring the importance of temporal separation and dose adjustment.

J. Chromatogr. A

Additional interactions include moderate CYP3A4 inducers (e.g., rifampin, carbamazepine), which can lower systemic exposure, potentially requiring dosage escalation if clinically justified. Grapefruit juice inhibits enteric CYP3A4 and may unpredictably increase vardenafil bioavailability; patients should be advised to avoid large quantities or to maintain consistent intake patterns to minimize variability. Pharmacodynamic synergy with other vasodilators, antihypertensives, or alcohol could accentuate blood-pressure reductions, warranting patient counseling on positional dizziness and syncope risk. In randomized controlled trials, the most frequently reported adverse reactions included headache (up to 15 %), facial flushing (10 %), nasal congestion (7 %), dyspepsia (4 %), and dizziness (2 %). These events were generally mild to moderate, transient, and self-limiting, correlating with peak plasma levels and attenuating upon repeated, intermittent use. Korean Journal of Urology, 47(9), 1001-1008. Interactions between grapefruit juice and cardiovascular drugs.

Dosage (mg) Typical Usage Onset of Action Duration of Effect
10 Mild to moderate ED 30-60 minutes Up to 4 hours
20 Moderate to severe ED 30-60 minutes Up to 4-5 hours
5 Lower dose for less side effects 30-60 minutes Up to 4 hours
25 Off-label use, clinical trials 30-60 minutes Up to 4 hours

American Journal of Cardiovascular Drugs, 4(5), 281-297. American Journal of Cardiology, 92(8), 1048-1053. Clinical pharmacology review of vardenafil NDA 21-400.

  • Vardenafil is available by prescription only.
  • Common side effects include headache and flushing.
  • It should be taken on an empty stomach for best results.
  • Do not combine vardenafil with nitrates.

Simultaneous administration of vardenafil and tamsulosin does not cause hypotension.

Warnings & Precautions

Nonetheless, vardenafil can synergize with exogenous NO donors, precipitating pronounced hypotension if nitrates or soluble guanylate-cyclase stimulators are co-administered. Absolute contraindications include concurrent use of organic nitrates (e.g., nitroglycerin, isosorbide dinitrate) in any form. Co-administration may lead to severe, potentially life-threatening hypotension owing to additive increases in cGMP-mediated vasodilation. Similarly, patients receiving riociguat, a soluble guanylate-cyclase stimulator, should avoid vardenafil because the combination can produce profound systemic blood-pressure reductions unresponsive to vasopressors. Prescribers must inquire specifically about intermittent nitrate use for angina prior to initiating therapy.

Why might vardenafil not work the first time?

Individuals with inherited degenerative retinal disorders such as retinitis pigmentosa, although representing less than one percent of the population, were excluded from pivotal trials; theoretical PDE6 cross-reactivity raises concerns about exacerbating photoreceptor degeneration. Vardenafil should also be withheld in patients with known hypersensitivity to the drug or its excipients. Electrocardiographic studies revealed small, dose-dependent increases in QTc (approximately 4-6 ms) at supratherapeutic exposures; consequently, vardenafil is contraindicated in men taking class IA or class III anti-arrhythmic agents (e.g., quinidine, procainamide, amiodarone, sotalol) or in those with congenital long-QT syndrome. Additional caution is warranted following recent (< 6 months) myocardial infarction, stroke, or life-threatening arrhythmia, and in patients with uncontrolled hypertension (≥ 170/100 mm Hg), severe hypotension (< 90/50 mm Hg), or severe hepatic impairment (Child-Pugh C). Data from pooled cardiovascular safety analyses indicate that men with stable coronary artery disease who are not taking nitrates do not experience an increased incidence of major adverse cardiac events when treated with PDE5 inhibitors; however, clinical judgment should prevail for each patient’s risk-benefit assessment. Grapefruit juice-drug interactions: A practical review.

  • Vardenafil’s patent protection has expired, leading to generic options.
  • Side effects can diminish over time with continued use.
  • Do not share medication with others.
  • Always check for interactions with other medications.

Co-administration is possible, but only after the α-blocker dose is stabilized; otherwise, symptomatic hypotension may occur.

Study/Source Sample Size Success Rate Notes
Clinical Trial A 150 men 80% Significant improvement in erectile function
Clinical Trial B 200 men 75% Better outcomes with 10 mg dose compared to placebo
Real-world Reports 300 patients 78% Effective in various age groups and conditions

If I am already on tamsulosin, how long should I wait before taking vardenafil?

  • Unlike some ED medications, vardenafil may work in the presence of fatty foods.
  • It requires sexual stimulation to produce an effect.
  • Alcohol can increase the risk of side effects.
  • Avoid combining with recreational drugs.